Clinical assessment in ischaemic cardiomyopathy

Nuclear Medicine Communications

Volumn 23, Issue 4, 2002, Pages 341-345

  Putz, E ^a   Vagelos, R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Heart failure; Remodeling; Revascularization; Viable myocardium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

CONFERENCE PAPER; CORONARY ARTERY DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGING; ISCHEMIC HEART DISEASE; MORTALITY; PATHOPHYSIOLOGY;

CORONARY ARTERIOSCLEROSIS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036238102     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200204000-00007     Document Type: Article

References (39)

1. National Heart, Lung, and Blood Institute. Morbidity, and Mortality. Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 1998.
2. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-1435.
3. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
4. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
5. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (Merit-HF). Lancet 1999; 353: 2001-2007.
6. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
7. Braunwald E, Kloner RA. The stunned myocardium: prolonged, post-ischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149.
8. Vanoverschelde JL, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the Study of Noninfarcted Collateral-Dependent Myocardium. Circulation 1993; 87: 1513-1523.
9. Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674-2680.
10. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
11. Eitzman D, al-Aouar Z, Kanter HL, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 20: 559-565.
12. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction; relative efficacy of medical therapy and revascularization. Circulation 1994; 90: 2687-2694.
13. Zafrir N, Leppo JA, Reinhardt CP, Dahlberg ST. Thallium reinjection versus standard stress/delay redistribution imaging for prediction of cardiac events. J Am Coll Cardiol 1998; 31: 1280-1285.
14. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32: 921-926.
15. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990; 82: 1629-1646.
16. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988; 319: 332-337.
17. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333-1339.
18. Bounous EP, Mark DB, Pollock BG, et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988; 78: 1151-1157.
19. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999; 34: 163-169.
20. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998; 32: 912-920.
21. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease. J Am Coll Cardiol 1997; 30: 1451-1460.
22. Pagano D, Townend J, Horton R, Littler W, Camici Pg, Bonser RS. Coronary artery bypass grafting for ischemic heart failure. The predictive value of quantitative PET for symptomatic and functional outcome. J Thorac Cardiovasc Surg 1998; 115: 791-799.
23. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple W. Quantitative planar rest-redistribution Tl-201 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 86: 1630-1641.
24. Di Carli MF, Asgaarrzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436-3444.
25. Pagano D, Camici PG, Bonser RS. Revascularisation for chronic heart failure: a valid option? Eur J Heart Failure 1999; 1: 269-273.
26. Louie H, Laks H, Milgalter E, et al. Ischaemic cardiomyopathy. Criteria for myocardial revascularization and cardiac transplantation. Circulation 1991; 86(Suppl. III): III-290-III-295.
27. Luciani GB, Faggian G, Razzolini R, Livi U, Bortolotti U, Mazzucco A. Severe ischaemic left ventricular failure: coronary operation of heart transplantation? Ann Thorac Surg 1993; 55: 719-723.
28. Milano CA, White WD, Smith LR, et al. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg 1993; 56: 487-493.
29. Mickleborough L, Maaruyama H, Tagaki T, Mohamed S, Sun Z, Ebisuzaki L. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995; 92(Suppl. II): II-73-II-79.
30. Faulkner S, Stoney W, Alford W, et al. Ischaemic cardiomyopathy medical versus surgical treatment. J Thorac Cardiovasc Surg 1977; 74: 77-82.
31. Kron IL, Flanagan TL, Blackbourne LF, Schroeder RA, Nolan SP. Coronary revascularization rather than cardiac transplantation for chronic ischaemic cardiomyopathy. Ann Surg 1989; 210: 348-354.
32. Elefteriades JA, Tolis Jr G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22: 1411-1417.
33. Lansman S, Cohen M, Galla J, et al. Coronary bypass with ejection fraction of 0.20 or less using centrigrade cardioplegia: long term follow-up. Ann Thorac Surg 1993; 56: 480-486.
34. Gunning M, Chua T, Harringhton D, et al. Hibernating myocardium: clinical and functional response to revascularization. Eur J Cardiothoracic Surg 1997; 11: 1105-1112.
35. Zeft HJ, Friedberg H, King JF, Manley JC, Huston JH, Johnson WD. Reappearance of anterior QRS forces after coronary bypass surgery; an electrovectorcardiographic study. Am J Cardiol 1975; 36: 163-168.
36. La Canna G, Raahimtoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000; 21: 1358-1367.
37. Geleijnse ML, Vigna C, Kasprzak JD, et al. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. Eur Heart J 2000; 21: 1666-1673.
38. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New Engl J Med 2000; 20: 1445-1453.
39. Pagano D, Bonser RS, Townen JN, Ordoubadi F, Lorenzoni R, Camici PC. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischemic heart failure. Heart 1998; 79: 281-288.